Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA
Keitaro Hayashi(Tohoku University), Hiroshi Shima(Miyagi Prefectural Hospital Organization), Y Sakamoto(Miyagi Prefectural Hospital Organization), Hiroshi Kiyonari(RIKEN Center for Biosystems Dynamics Research), Masato Sakayori(Miyagi Prefectural Hospital Organization), Masami Suganuma(Saitama University), Shigemi Ito(Miyagi Prefectural Hospital Organization), Mai Suzuki(Japanese Foundation For Cancer Research), Yui Inoue(Miyagi Prefectural Hospital Organization), Honami Ogoh(Nara Women's University), Nobuhiro Tanuma(Tohoku University), Iwao Sato(Tokyo Medical University), Makoto Nishio(Japanese Foundation For Cancer Research), Ayako Kishimoto(Nara Women's University), Hiroyuki Kato(Nagoya City University), Yuki Momoi(Miyagi Prefectural Hospital Organization), Katsumi Fukamachi(Nagoya City University), Toshio Watanabe(Nara Women's University), Yukitaka Yamashita(Miyagi Prefectural Hospital Organization), Miyuki Nomura(Miyagi Prefectural Hospital Organization), Yoichiro Kakugawa(Sendai Red Cross Hospital), Akira Suzuki(Chiba University)
Cited by 30
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
|The Lancet Respiratory Medicine|2019|937
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807